Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PORCUPINE: Zamaporvint +/- Nivolumab in RNF43/RSPO Aberrated MSS CRC
NCT04907539Phase 2Completed
- Sponsor
- Redx Pharma
- Start
- Nov 2021
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of zamaporvint in colorectal cancer (CRC), sponsored by Redx Pharma. Started Nov 2021; status: completed.
02
Drugs
zamaporvint
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04907539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907539.